Guardant Health Stock Z Score

GH Stock

USD 17.59 1.52 9.46%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Guardant Health Piotroski F Score and Guardant Health Valuation analysis.

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

As of now, Guardant Health's Issuance Of Capital Stock is increasing as compared to previous years. The Guardant Health's current Invested Capital is estimated to increase to 7.73, while Capital Surpluse is projected to decrease to under 1.1 B. As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Interest Expense is estimated to increase to about 2.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.

Guardant Health Company Z Score Analysis

Guardant Health's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Guardant Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Guardant Health is extremely important. It helps to project a fair market value of Guardant Stock properly, considering its historical fundamentals such as Z Score. Since Guardant Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Guardant Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Guardant Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Long Term Debt Total	Capital Surpluse	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Property Plant Equipment	Net Invested Capital	Net Working Capital	Intangible Assets	Deferred Long Term Liab	Capital Stock	Common Stock	Good Will
Total Assets		0.62	0.7	0.74	0.61	-0.73	0.45	0.9	0.92	0.69	0.89	0.97	0.87	-0.79	0.97	0.72	0.82	0.99	0.94	0.76	-0.33	-0.33	-0.33	-0.33
Total Stockholder Equity	0.62		0.97	0.32	-0.05	-0.01	-0.16	0.47	0.36	0.68	0.32	0.56	0.17	-0.58	0.64	0.02	0.25	0.68	0.65	0.78	0.15	0.15	0.15	0.15
Net Tangible Assets	0.7	0.97		0.44	0.07	-0.12	-0.03	0.6	0.47	0.73	0.43	0.67	0.28	-0.58	0.71	0.13	0.34	0.76	0.72	0.81	0.1	0.1	0.1	0.1
Current Deferred Revenue	0.74	0.32	0.44		0.52	-0.78	0.64	0.95	0.88	0.48	0.78	0.86	0.73	-0.84	0.73	0.76	0.68	0.75	0.64	0.41	-0.39	-0.39	-0.39	-0.39
Net Debt	0.61	-0.05	0.07	0.52		-0.63	0.82	0.63	0.77	0.52	0.65	0.59	0.75	-0.4	0.51	0.62	0.79	0.55	0.44	0.35	-0.11	-0.11	-0.11	-0.11
Retained Earnings	-0.73	-0.01	-0.12	-0.78	-0.63		-0.66	-0.78	-0.84	-0.24	-0.91	-0.78	-0.94	0.65	-0.72	-0.99	-0.72	-0.7	-0.67	-0.36	0.75	0.75	0.75	0.75
Accounts Payable	0.45	-0.16	-0.03	0.64	0.82	-0.66		0.59	0.67	0.52	0.58	0.56	0.63	-0.43	0.47	0.65	0.49	0.41	0.4	0.2	-0.18	-0.18	-0.18	-0.18
Long Term Debt	0.9	0.47	0.6	0.95	0.63	-0.78	0.59		0.97	0.6	0.88	0.96	0.83	-0.85	0.85	0.77	0.83	0.9	0.78	0.62	-0.35	-0.35	-0.35	-0.35
Net Receivables	0.92	0.36	0.47	0.88	0.77	-0.84	0.67	0.97		0.58	0.92	0.95	0.91	-0.81	0.85	0.83	0.91	0.89	0.77	0.6	-0.36	-0.36	-0.36	-0.36
Short Term Investments	0.69	0.68	0.73	0.48	0.52	-0.24	0.52	0.6	0.58		0.45	0.67	0.41	-0.56	0.73	0.23	0.39	0.71	0.72	0.69	0.26	0.26	0.26	0.26
Long Term Debt Total	0.89	0.32	0.43	0.78	0.65	-0.91	0.58	0.88	0.92	0.45		0.9	0.94	-0.73	0.84	0.93	0.82	0.87	0.8	0.69	-0.61	-0.61	-0.61	-0.61
Capital Surpluse	0.97	0.56	0.67	0.86	0.59	-0.78	0.56	0.96	0.95	0.67	0.9		0.85	-0.81	0.96	0.77	0.79	0.96	0.91	0.69	-0.34	-0.34	-0.34	-0.34
Total Liab	0.87	0.17	0.28	0.73	0.75	-0.94	0.63	0.83	0.91	0.41	0.94	0.85		-0.66	0.82	0.93	0.85	0.83	0.78	0.52	-0.62	-0.62	-0.62	-0.62
Short Long Term Debt	-0.79	-0.58	-0.58	-0.84	-0.4	0.65	-0.43	-0.85	-0.81	-0.56	-0.73	-0.81	-0.66		-0.77	-0.63	-0.62	-0.79	-0.69	-0.6	0.35	0.35	0.35	0.35
Total Current Assets	0.97	0.64	0.71	0.73	0.51	-0.72	0.47	0.85	0.85	0.73	0.84	0.96	0.82	-0.77		0.7	0.68	0.97	0.99	0.72	-0.34	-0.34	-0.34	-0.34
Short Term Debt	0.72	0.02	0.13	0.76	0.62	-0.99	0.65	0.77	0.83	0.23	0.93	0.77	0.93	-0.63	0.7		0.72	0.7	0.66	0.42	-0.77	-0.77	-0.77	-0.77
Property Plant Equipment	0.82	0.25	0.34	0.68	0.79	-0.72	0.49	0.83	0.91	0.39	0.82	0.79	0.85	-0.62	0.68	0.72		0.77	0.6	0.51	-0.28	-0.28	-0.28	-0.28
Net Invested Capital	0.99	0.68	0.76	0.75	0.55	-0.7	0.41	0.9	0.89	0.71	0.87	0.96	0.83	-0.79	0.97	0.7	0.77		0.95	0.8	-0.33	-0.33	-0.33	-0.33
Net Working Capital	0.94	0.65	0.72	0.64	0.44	-0.67	0.4	0.78	0.77	0.72	0.8	0.91	0.78	-0.69	0.99	0.66	0.6	0.95		0.73	-0.35	-0.35	-0.35	-0.35
Intangible Assets	0.76	0.78	0.81	0.41	0.35	-0.36	0.2	0.62	0.6	0.69	0.69	0.69	0.52	-0.6	0.72	0.42	0.51	0.8	0.73		-0.16	-0.16	-0.16	-0.16
Deferred Long Term Liab	-0.33	0.15	0.1	-0.39	-0.11	0.75	-0.18	-0.35	-0.36	0.26	-0.61	-0.34	-0.62	0.35	-0.34	-0.77	-0.28	-0.33	-0.35	-0.16		1.0	1.0	1.0
Capital Stock	-0.33	0.15	0.1	-0.39	-0.11	0.75	-0.18	-0.35	-0.36	0.26	-0.61	-0.34	-0.62	0.35	-0.34	-0.77	-0.28	-0.33	-0.35	-0.16	1.0		1.0	1.0
Common Stock	-0.33	0.15	0.1	-0.39	-0.11	0.75	-0.18	-0.35	-0.36	0.26	-0.61	-0.34	-0.62	0.35	-0.34	-0.77	-0.28	-0.33	-0.35	-0.16	1.0	1.0		1.0
Good Will	-0.33	0.15	0.1	-0.39	-0.11	0.75	-0.18	-0.35	-0.36	0.26	-0.61	-0.34	-0.62	0.35	-0.34	-0.77	-0.28	-0.33	-0.35	-0.16	1.0	1.0	1.0

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Guardant Health

According to the company's disclosures, Guardant Health has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Providers & Services sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Guardant Health Institutional Holders

Institutional Holdings refers to the ownership stake in Guardant Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Guardant Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Guardant Health's value.

		Shares
Geode Capital Management, Llc	2023-12-31	2.5 M
Morgan Stanley - Brokerage Accounts	2023-12-31	2.5 M
Capital Research Global Investors	2023-12-31	2.3 M
Fidelity International Ltd	2023-12-31	2 M
T. Rowe Price Associates, Inc.	2023-12-31	1.8 M
Goldman Sachs Group Inc	2023-12-31	1.8 M
Credit Suisse First Boston (csfb)	2023-12-31	1.8 M
Clearbridge Advisors, Llc	2023-12-31	1.5 M
Franklin Resources Inc	2023-12-31	1.4 M
Vanguard Group Inc	2023-12-31	11.1 M
Blackrock Inc	2023-12-31	10.8 M

Guardant Fundamentals

	Return On Equity	-4.38
	Return On Asset	-0.18
	Profit Margin	(0.85) %
	Operating Margin	(0.73) %
	Current Valuation	2.14 B
	Shares Outstanding	121.71 M
	Shares Owned By Insiders	4.10 %
	Shares Owned By Institutions	93.58 %
	Number Of Shares Shorted	7.64 M
	Price To Earning	(12.01) X
	Price To Book	14.01 X
	Price To Sales	3.94 X
	Revenue	563.95 M
	Gross Profit	293.21 M
	EBITDA	(519.63 M)
	Net Income	(479.45 M)
	Cash And Equivalents	853.69 M
	Cash Per Share	8.35 X
	Total Debt	1.35 B
	Debt To Equity	4.32 %
	Current Ratio	6.18 X
	Book Value Per Share	1.30 X
	Cash Flow From Operations	(324.98 M)
	Short Ratio	4.10 X
	Earnings Per Share	(4.28) X
	Price To Earnings To Growth	(0.66) X
	Target Price	39.06
	Number Of Employees	1.77 K
	Beta	0.9
	Market Capitalization	1.96 B
	Total Asset	1.79 B
	Retained Earnings	(2.14 B)
	Working Capital	1.14 B
	Current Asset	219.68 M
	Current Liabilities	24.24 M
	Net Asset	1.79 B

About Guardant Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock:

How To Invest In Guardant

Details

Is Guardant Stock a good investment?

Details

What is Guardant Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Guardant Health Piotroski F Score and Guardant Health Valuation analysis.

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.

	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Transaction History View history of all your transactions and understand their impact on performance
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences

Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.28)

Revenue Per Share

5.036

Quarterly Revenue Growth

0.222

Return On Assets

(0.18)

Return On Equity

(4.38)

The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Guardant Health Stock Z Score

Guardant Health Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Guardant Z Score Driver Correlations

Guardant Health Institutional Holders

Guardant Fundamentals

About Guardant Health Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Guardant Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY